573 related articles for article (PubMed ID: 17120268)
1. Design, synthesis and pharmacological evaluation of cyclic mimetics of the insulin-like peptide 3 (INSL3) B-chain.
Shabanpoor F; Bathgate RA; Hossain MA; Giannakis E; Wade JD; Hughes RA
J Pept Sci; 2007 Feb; 13(2):113-20. PubMed ID: 17120268
[TBL] [Abstract][Full Text] [Related]
2. Design and development of analogues of dimers of insulin-like peptide 3 B-chain as high-affinity antagonists of the RXFP2 receptor.
Shabanpoor F; Zhang S; Hughes RA; Hossain MA; Layfield S; Ferraro T; Bathgate RA; Separovic F; Wade JD
Biopolymers; 2011; 96(1):81-7. PubMed ID: 20560146
[TBL] [Abstract][Full Text] [Related]
3. Role of the intra-A-chain disulfide bond of insulin-like peptide 3 in binding and activation of its receptor, RXFP2.
Zhang S; Hughes RA; Bathgate RA; Shabanpoor F; Hossain MA; Lin F; van Lierop B; Robinson AJ; Wade JD
Peptides; 2010 Sep; 31(9):1730-6. PubMed ID: 20570702
[TBL] [Abstract][Full Text] [Related]
4. Effect of helix-promoting strategies on the biological activity of novel analogues of the B-chain of INSL3.
Shabanpoor F; Hughes RA; Zhang S; Bathgate RA; Layfield S; Hossain MA; Tregear GW; Separovic F; Wade JD
Amino Acids; 2010 Jan; 38(1):121-31. PubMed ID: 19067106
[TBL] [Abstract][Full Text] [Related]
5. Recombinant expression of an insulin-like peptide 3 (INSL3) precursor and its enzymatic conversion to mature human INSL3.
Luo X; Bathgate RA; Liu YL; Shao XX; Wade JD; Guo ZY
FEBS J; 2009 Sep; 276(18):5203-11. PubMed ID: 19674100
[TBL] [Abstract][Full Text] [Related]
6. Chemical synthesis and biological activity of rat INSL3.
Smith KJ; Wade JD; Claasz AA; Otvos L; Temelcos C; Kubota Y; Hutson JM; Tregear GW; Bathgate RA
J Pept Sci; 2001 Sep; 7(9):495-501. PubMed ID: 11587188
[TBL] [Abstract][Full Text] [Related]
7. Conformationally constrained single-chain peptide mimics of relaxin B-chain secondary structure.
Del Borgo MP; Hughes RA; Wade JD
J Pept Sci; 2005 Sep; 11(9):564-71. PubMed ID: 15742332
[TBL] [Abstract][Full Text] [Related]
8. Solid-phase synthesis of europium-labeled human INSL3 as a novel probe for the study of ligand-receptor interactions.
Shabanpoor F; Hughes RA; Bathgate RA; Zhang S; Scanlon DB; Lin F; Hossain MA; Separovic F; Wade JD
Bioconjug Chem; 2008 Jul; 19(7):1456-63. PubMed ID: 18529069
[TBL] [Abstract][Full Text] [Related]
9. Defining the LGR8 residues involved in binding insulin-like peptide 3.
Scott DJ; Wilkinson TN; Zhang S; Ferraro T; Wade JD; Tregear GW; Bathgate RA
Mol Endocrinol; 2007 Jul; 21(7):1699-712. PubMed ID: 17473281
[TBL] [Abstract][Full Text] [Related]
10. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8).
Halls ML; Bond CP; Sudo S; Kumagai J; Ferraro T; Layfield S; Bathgate RA; Summers RJ
J Pharmacol Exp Ther; 2005 May; 313(2):677-87. PubMed ID: 15649866
[TBL] [Abstract][Full Text] [Related]
11. Analogs of insulin-like peptide 3 (INSL3) B-chain are LGR8 antagonists in vitro and in vivo.
Del Borgo MP; Hughes RA; Bathgate RAD; Lin F; Kawamura K; Wade JD
J Biol Chem; 2006 May; 281(19):13068-13074. PubMed ID: 16547350
[TBL] [Abstract][Full Text] [Related]
12. Leucine-rich repeat-containing G-protein-coupled receptor 8 in mature glomeruli of developing and adult rat kidney and inhibition by insulin-like peptide-3 of glomerular cell proliferation.
Fu P; Shen PJ; Zhao CX; Scott DJ; Samuel CS; Wade JD; Tregear GW; Bathgate RA; Gundlach AL
J Endocrinol; 2006 May; 189(2):397-408. PubMed ID: 16648305
[TBL] [Abstract][Full Text] [Related]
13. Mono- and bicyclic analogs of parathyroid hormone-related protein. 1. Synthesis and biological studies.
Bisello A; Nakamoto C; Rosenblatt M; Chorev M
Biochemistry; 1997 Mar; 36(11):3293-9. PubMed ID: 9116007
[TBL] [Abstract][Full Text] [Related]
14. Synthetic human insulin 4 does not activate the G-protein-coupled receptors LGR7 or LGR8.
Lin F; Otvos L; Kumagai J; Tregear GW; Bathgate RA; Wade JD
J Pept Sci; 2004 May; 10(5):257-64. PubMed ID: 15160837
[TBL] [Abstract][Full Text] [Related]
15. The "hot wires" of the relaxin-like factor (Insl3).
Schwabe C; Büllesbach EE
Ann N Y Acad Sci; 2009 Apr; 1160():93-8. PubMed ID: 19416166
[TBL] [Abstract][Full Text] [Related]
16. Structure of human insulin-like peptide 5 and characterization of conserved hydrogen bonds and electrostatic interactions within the relaxin framework.
Haugaard-Jönsson LM; Hossain MA; Daly NL; Craik DJ; Wade JD; Rosengren KJ
Biochem J; 2009 May; 419(3):619-27. PubMed ID: 19178384
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, conformation, receptor binding and biological activities of monobiotinylated human insulin-like peptide 3.
Fu P; Layfield S; Ferraro T; Tomiyama H; Hutson J; Otvos L; Tregear GW; Bathgate RA; Wade JD
J Pept Res; 2004 Feb; 63(2):91-8. PubMed ID: 15009530
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the rat INSL3 receptor.
Scott DJ; Fu P; Shen PJ; Gundlach A; Layfield S; Riesewijk A; Tomiyama H; Hutson JM; Tregear GW; Bathgate RA
Ann N Y Acad Sci; 2005 May; 1041():13-6. PubMed ID: 15956681
[TBL] [Abstract][Full Text] [Related]
19. Relaxin research in the postgenomic era.
Kawamura K; Sudo S; Kumagai J; Pisarska M; Hsu SY; Bathgate R; Wade J; Hsueh AJ
Ann N Y Acad Sci; 2005 May; 1041():1-7. PubMed ID: 15956679
[TBL] [Abstract][Full Text] [Related]
20. Detection, localization, and action of the INSL3 receptor, LGR8, in rat kidney.
Fu P; Shen PJ; Zhao CX; Scott DJ; Samuel CS; Wade JD; Tregear GW; Bathgate RA; Gundlach AL
Ann N Y Acad Sci; 2005 May; 1041():516-9. PubMed ID: 15956754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
